SARAH LAWSON: Open Payments
NPI 1114452604 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,460 in 146 payments from 16 companies in 2025. Trend: 2023 $2,265 · 2024 $2,349 · 2025 $2,460
Food & beverage: $2,226Education: $234
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $359 |
| ABBVIE INC. | 27 | $359 |
| UCB, Inc. | 12 | $344 |
| Galderma Laboratories, L.P. | 23 | $211 |
| Novartis Pharmaceuticals Corporation | 8 | $184 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $180 |
| Regeneron Healthcare Solutions, Inc. | 18 | $160 |
| Incyte Corporation | 7 | $155 |
| Amgen Inc. | 8 | $140 |
| GENZYME CORPORATION | 6 | $121 |
Products named: TREMFYA, DUPIXENT, Bimzelx, RINVOQ, NEMLUVIO, OPZELURA, ILUMYA, OTEZLA.
Industry payments across IN — which companies pay providers there.
